EA201270186A1 - Фармацевтические композиции, содержащие модифицированные фуканы, для использования при лечении фиброзных спаек и других нарушений - Google Patents
Фармацевтические композиции, содержащие модифицированные фуканы, для использования при лечении фиброзных спаек и других нарушенийInfo
- Publication number
- EA201270186A1 EA201270186A1 EA201270186A EA201270186A EA201270186A1 EA 201270186 A1 EA201270186 A1 EA 201270186A1 EA 201270186 A EA201270186 A EA 201270186A EA 201270186 A EA201270186 A EA 201270186A EA 201270186 A1 EA201270186 A1 EA 201270186A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- fukans
- violations
- pharmaceutical compositions
- compositions containing
- containing modified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Surgery (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Композиция, содержащая агенты фукана и применение указанных композиций для лечения, профилактики, ингибирования и т.д. фиброзных спаек, перитонита, ишемии, реперфузионного поражения, эндотоксикоза, келоидов и рубцевания в виде келоидного шва, дерматита и розацеа. Предпочтительные агенты фукана отличаются распределением их молекулярной массы.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22892909P | 2009-07-27 | 2009-07-27 | |
PCT/CA2010/001175 WO2011011881A1 (en) | 2009-07-27 | 2010-07-27 | Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201270186A1 true EA201270186A1 (ru) | 2012-09-28 |
Family
ID=43497856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201270186A EA201270186A1 (ru) | 2009-07-27 | 2010-07-27 | Фармацевтические композиции, содержащие модифицированные фуканы, для использования при лечении фиброзных спаек и других нарушений |
Country Status (19)
Country | Link |
---|---|
US (6) | US8466125B2 (ru) |
EP (2) | EP3300737A1 (ru) |
JP (5) | JP2013500274A (ru) |
KR (1) | KR20120083297A (ru) |
CN (2) | CN106176798A (ru) |
AR (1) | AR078082A1 (ru) |
AU (4) | AU2010278640A1 (ru) |
BR (1) | BR112012008072A2 (ru) |
CA (2) | CA3046665C (ru) |
CL (1) | CL2012000215A1 (ru) |
EA (1) | EA201270186A1 (ru) |
IN (1) | IN2012DN01314A (ru) |
JO (1) | JO3676B1 (ru) |
MX (1) | MX2012001212A (ru) |
MY (1) | MY168759A (ru) |
SG (3) | SG10201808960VA (ru) |
TW (2) | TWI569801B (ru) |
WO (1) | WO2011011881A1 (ru) |
ZA (1) | ZA201200999B (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11628183B2 (en) | 2018-07-27 | 2023-04-18 | ARC Medical Ine. | Highly purified fucans for the treatment of fibrous adhesions |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1809303B1 (en) * | 2004-09-23 | 2019-03-06 | ARC Medical Devices, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
JO3676B1 (ar) * | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
WO2011109469A1 (en) * | 2010-03-03 | 2011-09-09 | Neocutis Sa | Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
FR2984126B1 (fr) * | 2011-12-20 | 2014-08-22 | Oreal | Polysaccharides sulfates agent antipelliculaire |
CA2976142A1 (en) | 2015-02-16 | 2016-08-25 | Gilles Henri LASSERRE | Composition for prevention or treatment of cutaneous disorder |
CN105663154B (zh) * | 2016-01-18 | 2020-06-30 | 首都医科大学 | 褐藻多糖硫酸酯在制备预防和/或治疗下肢外周动脉血管病的产品中的应用 |
US20180056087A1 (en) * | 2016-08-26 | 2018-03-01 | Adolfo Ribeiro | Wearable Micro-LED Healing Bandage |
CN106943619A (zh) * | 2017-03-17 | 2017-07-14 | 清华大学 | 一种液体伤口敷料及其制备方法 |
CN115260328A (zh) * | 2022-08-14 | 2022-11-01 | 湘潭大学 | 一种改性岩藻多糖化合物及其制备方法和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
IT1288713B1 (it) * | 1996-12-18 | 1998-09-23 | Crinos Industria Farmaco | Fucani a basso peso molecolare aventi attivita' anticoagulante antitrombinica e antitrombotica |
FR2772618B1 (fr) * | 1997-12-18 | 2000-02-18 | Ifremer | Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs |
ATE367166T1 (de) * | 1999-08-20 | 2007-08-15 | Takara Bio Inc | Heilmittel |
US6812220B2 (en) * | 2001-08-29 | 2004-11-02 | University Of British Columbia | Pharmaceutical compositions and methods relating to fucans |
NO320671B1 (no) * | 2001-11-30 | 2006-01-16 | Fmc Biopolymer As | Fremgangsmate for a stimulere vektokning i fisk. |
CN1829501A (zh) | 2003-05-30 | 2006-09-06 | Arc药品有限公司 | 涉及使用多种药物抑制纤维粘连的药用组合物和方法 |
BRPI0418384A (pt) * | 2003-05-30 | 2007-06-26 | Arc Pharmaceuticals Inc | composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes |
EP1809303B1 (en) * | 2004-09-23 | 2019-03-06 | ARC Medical Devices, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
WO2007028256A2 (en) * | 2005-09-09 | 2007-03-15 | Les Biotechnologies Oceanova Inc. | Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
CN1935154A (zh) * | 2006-09-04 | 2007-03-28 | 北京世纪博康医药科技有限公司 | 褐藻多糖硫酸酯在制备治疗心脑血管疾病的药物中的用途 |
KR101486931B1 (ko) * | 2007-02-23 | 2015-01-27 | 박스터 인터내쇼날 인코포레이티드 | 해조류 추출물로부터 푸코이단을 정제하는 방법 |
GB0707096D0 (en) * | 2007-04-12 | 2007-05-23 | Ntnu Technology Transfer As | Method |
JO3676B1 (ar) * | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
-
2010
- 2010-07-25 JO JOP/2010/0261A patent/JO3676B1/ar active
- 2010-07-26 TW TW104117619A patent/TWI569801B/zh not_active IP Right Cessation
- 2010-07-26 TW TW099124495A patent/TWI491396B/zh active
- 2010-07-27 EA EA201270186A patent/EA201270186A1/ru unknown
- 2010-07-27 CA CA3046665A patent/CA3046665C/en active Active
- 2010-07-27 AR ARP100102706A patent/AR078082A1/es not_active Application Discontinuation
- 2010-07-27 CA CA2769147A patent/CA2769147A1/en not_active Abandoned
- 2010-07-27 EP EP17193478.9A patent/EP3300737A1/en not_active Withdrawn
- 2010-07-27 WO PCT/CA2010/001175 patent/WO2011011881A1/en active Application Filing
- 2010-07-27 MY MYPI2012000343A patent/MY168759A/en unknown
- 2010-07-27 CN CN201610545789.8A patent/CN106176798A/zh active Pending
- 2010-07-27 SG SG10201808960VA patent/SG10201808960VA/en unknown
- 2010-07-27 KR KR1020127004988A patent/KR20120083297A/ko not_active Application Discontinuation
- 2010-07-27 MX MX2012001212A patent/MX2012001212A/es active IP Right Grant
- 2010-07-27 SG SG10201401436VA patent/SG10201401436VA/en unknown
- 2010-07-27 CN CN201080042840.4A patent/CN102665733B/zh active Active
- 2010-07-27 AU AU2010278640A patent/AU2010278640A1/en not_active Abandoned
- 2010-07-27 US US12/843,992 patent/US8466125B2/en active Active
- 2010-07-27 SG SG2012005104A patent/SG177741A1/en unknown
- 2010-07-27 EP EP10803778A patent/EP2459200A4/en not_active Ceased
- 2010-07-27 BR BR112012008072A patent/BR112012008072A2/pt not_active Application Discontinuation
- 2010-07-27 JP JP2012521918A patent/JP2013500274A/ja active Pending
-
2012
- 2012-01-26 CL CL2012000215A patent/CL2012000215A1/es unknown
- 2012-02-10 ZA ZA2012/00999A patent/ZA201200999B/en unknown
- 2012-02-13 IN IN1314DEN2012 patent/IN2012DN01314A/en unknown
-
2013
- 2013-06-14 US US13/918,544 patent/US20140128340A1/en not_active Abandoned
-
2014
- 2014-05-27 US US14/287,307 patent/US20140274942A1/en not_active Abandoned
-
2016
- 2016-02-04 JP JP2016019894A patent/JP2016128491A/ja active Pending
- 2016-08-24 AU AU2016219615A patent/AU2016219615A1/en not_active Abandoned
- 2016-09-22 US US15/272,949 patent/US20180051097A1/en not_active Abandoned
-
2017
- 2017-07-03 JP JP2017130195A patent/JP2017206542A/ja active Pending
- 2017-09-27 US US15/717,681 patent/US20180230240A1/en not_active Abandoned
-
2018
- 2018-05-16 AU AU2018203461A patent/AU2018203461A1/en not_active Abandoned
-
2019
- 2019-04-03 JP JP2019071611A patent/JP2019142896A/ja active Pending
- 2019-05-17 US US16/415,397 patent/US20200115472A1/en not_active Abandoned
- 2019-11-20 AU AU2019268096A patent/AU2019268096A1/en not_active Abandoned
-
2020
- 2020-09-30 JP JP2020164770A patent/JP2021020907A/ja active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11628183B2 (en) | 2018-07-27 | 2023-04-18 | ARC Medical Ine. | Highly purified fucans for the treatment of fibrous adhesions |
US11642368B2 (en) | 2018-07-27 | 2023-05-09 | ARC Medical Inc. | Highly purified and/or modified fucan compositions for the treatment of fibrous adhesions |
US11938145B2 (en) | 2018-07-27 | 2024-03-26 | ARC Medical Inc. | Low endotoxin fucan compositions, systems, and methods |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270186A1 (ru) | Фармацевтические композиции, содержащие модифицированные фуканы, для использования при лечении фиброзных спаек и других нарушений | |
CY1119660T1 (el) | Antibakthpiakh απο toy στοματος συνθεση | |
BR112015007878A2 (pt) | composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos | |
MX361467B (es) | Compuestos de isoindolina para uso en el tratamiento de cancer. | |
EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
BR112012011485A2 (pt) | "composições e métodos para tratar náusea e vômito centralmente mediados". | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
EA201290506A1 (ru) | Частицы для доставки множества агентов | |
EA201300898A1 (ru) | Композиция для окислительного фотоактивируемого омоложения кожи, содержащая гиалуроновую кислоту, глюкозамин или аллантоин | |
CL2008001633A1 (es) | Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer. | |
MX340533B (es) | Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas. | |
CR20120202A (es) | Métodos y composiciones para tratar cáncer | |
MX349886B (es) | Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas. | |
SV2011003907A (es) | Composiciones antimicrobianas | |
EA201190198A1 (ru) | Композиция и пленка, содержащая полиолефин, включающий с-сальфа-олефин | |
MX2013004759A (es) | Compuestos de oxima como agentes de elevacion de colesterol de lipoproteina de alta densidad (hdl). | |
MX2010002667A (es) | Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3. | |
BR112013022217A8 (pt) | composição farmacêutica, método de tratamento preventivo de uma síndrome hemorrágica em um paciente com hemofilia a ou b e método de tratamento de um acidente hemorrágico em um paciente com hemofilia a ou b | |
WO2012050641A3 (en) | Use of trpa1 antagonists to prevent or treat infections caused by biological-warfare agents | |
WO2010074936A3 (en) | Enzastaurin for the treatment of cancer | |
TN2013000333A1 (en) | Combinations comprising macitentan for the treatment of glioblastoma multiforme | |
WO2008036377A3 (en) | Novel triclosan salts | |
HK1137947A1 (en) | Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria | |
ATE538799T1 (de) | Zusammensetzungen zur behandlung von haarverlust |